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Sir: It is hypothesized that increased
intestinal permeability can induce
or enhance septic complications in
intensive care patients by facilitating
bacterial translocation. A reliable
and safe detection method would
aid in identifying patients with
increased intestinal permeability.
Intestinal permeability has frequently
been measured by tests based on
the differential sugar absorption
principle. In these tests the ratio
of urinary recovery after orally
administration of a small permeant
sugar probe and large sugar probe,
impermeant in the uncompromised
intestine, is used as an indication
of intestinal permeability [1].
The principle of these tests is
that premucosal factors (i.e.,
gastric retention) and postmucosal
factors (i.e., metabolism and renal
function) are excluded because these
should affect both probes similarly.
Therefore only mucosal factors (i.e.,
intestinal permeability) is indicated.
The most commonly used test is
the lactulose mannitol test (LMT).
Oudemans-van Straaten etal. [2]
identiﬁed confounding factors when
performing the LMT in ICU patients.
Their study was conductedin severely
ill patientswith multiple organfailure.
The LMT could still be applicable in
patients with milder disease.
We performed the LMT on trauma
patients admitted to an ICU, in-
cluding all patients, with a variety
of injury severity. Thirteen trauma
patients were included who under-
went three tests each. The trauma
patients’ median Injury Severity
Score was 24 (range 16–38). Renal
function was within normal range in
all patients (creatinine< 120µmol/l;
ureum<7.5µmol/l). In 19 tests
(61%) confounding factors were
identiﬁed. Of the confounding factors
53% were therapy related (i.e., man-
nitol use as therapeutic agent or in
saline adenosine glucose mannitol).
In the remaining 47% of biased
tests, the factors consisted of ad-
ministering problems (i.e., stomach
retention).
Thus two groups of confounding
factors cause a problem: (a) the
use of test substances for clinical
applications and (b) administering
problems with the test solution.
The ﬁrst problem affects the probes
differently, thus causing invalid
test results. This can be overcome
by discarding mannitol as probe. The
administering problem affects the
two probes similarly, and thus the
ratio remains constant. In the case of
gastric retention probes do not reach
the intestine and cannot be measured
in urine. A solution would be to
administer the test ﬂuid in the small
intestine by a nasoduodenaltube.
We conclude, and stress this as
a warning to future researchers, that
the LMT is inappropriate not only for
patients with multiple organ failure
but also for trauma patients in an ICU
setting (without organ failure).
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